EU22CEAPR1/SES110 - Q&A - Panel Discussion with Speakers of Track 1

Description

Speaker(s):

• Greg Carr, CMC Regulatory Affairs Senior Director and Group Manager, AstraZeneca
• Dimitrios Catsoulacos, Technical Officer - Expert Inspector, WHO
• Sanja S. Karlsson, SUDDEN Project Coordinator, University of Helsinki
• Per Niklasson, Regulatory CMC Director, AstraZeneca